The mechanisms of recombination in human immunodeficiency virus;Caractéristiques mécanistiques de la recombinaison chez le virus de l'immunodéficience humaine

Virologie

Volumn 10, Issue 6, 2006, Pages 431-442

  Simon Loriere E ^a   Galetto, R ^a   Negroni, M ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

HIV; Molecular mechanism; Recombination

Indexed keywords

GENOMIC RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL FEATURE; DNA STRAND BREAKAGE; DNA SYNTHESIS; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PREVALENCE; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION; REVIEW; RISK FACTOR; RNA STRUCTURE; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS PARTICLE; VIRUS RECOMBINATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33847314650     PISSN: 12678694     EISSN: None     Source Type: Journal    
DOI: 10.1684/vir.2006.0040     Document Type: Review

References (110)

1. Hahn BH, Shaw GM, De Cock KM, Sharp PM. AIDS as a zoonosis : scientific and public health implications. Science 2000 ; 287 : 607-14.
2. Gao F, Bailes E, Robertson DL, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999 ; 397 : 436-41.
3. Robertson DL, Anderson JP, Bradac JA, et al. In : Human Retroviruses and AIDS 1999. Los Alamos, NM : Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, 1999 : 492-505.
4. Robertson DL, Anderson JP, Bradac JA, et al. HIV-1 nomenclature proposal. Science 2000 ; 288 : 55-6.
5. Thomson MM, Perez-Alvarez L, Najera R. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2002 ; 2 : 461-71.
6. Vidai N, Peeters M, Mulanga-Kabeya C, et al. Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the democratic republic of congo suggests that the HIV-1 pandemic originated in central africa. J Virol 2000 ; 74 : 10498-507.
7. Peeters M, Toure-Kane C, Nkengasong JN. Genetic diversity of HIV in Africa : impact on diagnosis, treatment, vaccine development and trials. AIDS 2003 ; 17 : 2547-60.
8. Peeters M, Gueye A, Mboup S, et al. Geographical distribution of HIV-1 group O viruses in Africa. AIDS 1997 ; 11 : 493-8.
9. Ayouba A, Souquieres S, Njinku B, et al. HIV-1 group N among HIV-1-seropositive individuals in Cameroon. AIDS 2000 ; 14 : 2623-5.
10. Damond F, Worobey M, Campa P, et al. Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification. AIDS Res Hum Retroviruses 2004 ; 20 : 666-72.
11. Rambaut A, Posada D, Crandall KA, Holmes EC. The causes and consequences of HIV evolution. Nat Rev Genet 2004 ; 5 : 52-61.
12. The Circulating Recombinant Forms (CRFs). Los Alamos National Laboratory. HIV Sequence Database http://hiv-web.lanl.gov/content/hiv-db/ CRFs/CRFs.html.
13. Osmanov S, Pattou C, Walker N, Schwardlander B, Esparza J. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 2002 ; 29 : 184-90.
14. Takehisa J, Zekeng L, Ido E, et al. Human immunodeficiency virus type 1 intergroup (M/O) recombination in Cameroon. J Virol 1999 ; 73 : 6810-20.
15. Peeters M, Liegeois F, Torimiro N, et al. Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. J Virol 1999 ; 73 : 7368-75.
16. McVean G, Awadalla P, Fearnhead P. A coalescent-based method for detecting and estimating recombination from gene sequences. Genetics 2002 ; 160 : 1231-41.
17. Vogt PK. Genetically stable reassortment of markers during mixed infection with avian tumor viruses. Virology 1971 ; 46 : 947-52.
18. Hu WS, Temin HM. Genetic consequences of packaging two RNA genomes in one retroviral particle : pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci USA 1990 ; 87 : 1556-60.
19. Clavel F, Hoggan MD, Willey RL, Strebel K, Martin MA, Repaske R. Genetic recombination of human immunodeficiency virus. J Virol 1989 ; 63 : 1455-9.
20. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995 ; 373 : 123-6.
21. Preston BD, Poiesz BJ, Loeb LA. Fidelity of HIV-1 reverse transcriptase. Science 1988 ; 242 : 1168-71.
22. Hu WS, Temin HM. Retroviral recombination and reverse transcription. Science 1990 ; 250 : 1227-33.
23. Mansky LM, Temin HM. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 1995 ; 69 : 5087-94.
24. Piguet V, Schwartz O, Le Gall S, Trono D. The downregulation of CD4 and MHC-I by primate lentiviruses : a paradigm for the modulation of cell surface receptors. Immunol Rev 1999 ; 168 : 51-63.
25. Jung A, Maier R, Vartanian JP, et al. Multiply infected spleen cells in HIV patients. Nature 2002 ; 11 : 418 ; (144).
26. Fang G, Weiser B, Kuiken C, et al. Recombination following superinfection by HIV-1. AIDS 2004 ; 18 : 153-9.
27. Levy DN, Aldrovandi GM, Kutsch O, Shaw GM. Dynamics of HIV-1 recombination in its natural target cells. Proc Natl Acad Sci USA 2004 ; 101 : 4204-9.
28. McDonald D, Wu L, Bohks SM, KewalRamani VN, Unutmaz D, Hope TJ. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 2003 ; 300 : 1295-7.
29. Berger EA, Doms RW, Fenyo EM, et al. A new classification for HIV-1. Nature 1998 ; 391 : 240.
30. Paillart JC, Shehu-Xhilaga M, Marquet R, Mak J. Dimerization of retroviral RNA genomes : an inseparable pair. Nat Rev Microbiol 2004 ; 2 : 461-72.
31. Chin MP, Rhodes TD, Chen J, Fu W, Hu WS. Identification of a major restriction in HIV-1 intersubtype recombination. Proc Natl Acad Sci USA 2005 ; 102 : 9002-7.
32. Onafuwa A, An W, Robson ND, Telesnitsky A. Human immunodeficiency virus type 1 genetic recombination is more frequent than that of Moloney murine leukemia virus despite similar template switching rates. J Virol 2003 ; 77 : 4577-87.
33. Flynn JA, Telesnitsky A. Two distinct Moloney murine leukemia virus RNAs produced from a single locus dimerize at random. Virology 2006 ; 344 : 391-400.
34. Anderson JA, Bowman EH, Hu WS. Retroviral recombination rates do not increase linearly with marker distance and are limited by the size of the recombining subpopulation. J Virol 1998 ; 72 : 1195-202.
35. Yu H, Jetzt AE, Ron Y, Preston BD, Dougherty JP. The nature of human immunodeficiency virus type 1 strand transfers. J Biol Chem 1998 ; 273 : 28384-91.
36. Zhang J, Tang LY, Li T, Ma Y, Sapp CM. Most retroviral recombinations occur during minus-strand DNA synthesis. J Virol 2000 ; 74 : 2313-22.
37. Jetzt AE, Yu H, Klarmann GJ, Ron Y, Preston BD, Dougherty JP. High rate of recombination throughout the human immunodeficiency virus type 1 genome. J Virol 2000 ; 74 : 1234-40.
38. Boone LR, Skalka AM. Strand displacement synthesis by reverse transcriptase. In : Skalka AM, Goff SP, eds. Reverse transcriptase. Cold Spring Harbor, New York : Cold Spring Harbor Laboratory Press, New York, USA, 1993.
39. Hu WS, Pathak VK, Temin HM. Role of reverse transcriptase in retroviral recombination. In : Skalka AM, Goff SP, eds. Reverse Transcriptase. Cold Spring Harbor : Cold Spring Harbor Laboratory Press, New York, USA, 1993 : 251-74.
40. Magiorkinis G, Paraskevis D, Vandamme AM, Magiorkinis E, Sypsa V, Hatzakis A. In vivo characteristics of human immunodeficiency virus type 1 intersubtype recombination : determination of hot spots and correlation with sequence similarity. J Gen Virol 2003 ; 84 : 2715-22.
41. Junghans RP, Boone LR, Skalka AM. Products of reverse transcription in avian retrovirus analyzed by electron microscopy. J Virol 1982 ; 43 : 544-54.
42. Junghans RP, Boone LR, Skalka AM. Retroviral DNA H structures : displacement-assimilation model of recombination. Cell 1982 ; 30 : 53-62.
43. Bowman RR, Hu WS, Pathak VK. Relative rates of retroviral reverse transcriptase template switching during RNA- and DNA-dependent DNA synthesis. J Virol 1998 ; 72 : 5198-206.
44. Vogt PK. The genome of avian RNA tumor viruses: a discussion of four models. In : Silvestri L, ed. Proceedings of the Fourth Le Petit Colloquium: Possible episomes in eukaryotes. Amsterdam : North Holland Publishing Co, 1973.
45. Oyama F, Kikuchi R, Crouch RJ, Uchida T. Intrinsic properties of reverse transcriptase in reverse transcription. Associated RNase H is essentially regarded as an endonuclease. J Biol Chem 1989 ; 264 : 18808-17.
46. Krug MS, Berger SL. Ribonuclease H activities associated with viral reverse transcriptases are endonucleases. Proc Natl Acad Sci USA 1989 ; 86 : 3539-43.
47. Wisniewski M, Balakrishnan M, Palaniappan C, Fay PJ, Bambara RA. The sequential mechanism of HIV reverse transcriptase RNase H. J Biol Chem 2000 ; 275 : 37664-71.
48. Schultz SJ, Zhang M, Champoux JJ. Recognition of internal cleavage sites by retroviral RNases H. J Mol Biol 2004 ; 344 : 635-52.
49. Telesnitsky A, Goff SP. Two defective forms of reverse transcriptase can complement to restore retroviral infectivity. EMBO J 1993 ; 12 : 4433-8.
50. Coffin JM. Structure, replication, and recombination of retrovirus genomes : some unifying hypotheses. J Gen Virol 1979 ; 42 : 1-26.
51. Wisniewski M, Balakrishnan M, Palaniappan C, Fay PJ, Bambara RA. Unique progressive cleavage mechanism of HIV reverse transcriptase RNase H. Proc Natl Acad Sci USA 2000 ; 97 : 11978-83.
52. Ben-Artzi H, Zeelon E, Amit B, Wortzel A, Gorecki M, Panet A. RNase H activity of reverse transcriptases on substrates derived from the 5′ end of retroviral genome. J Biol Chem 1993 ; 268 : 16465-71.
53. Peliska JA, Benkovic SJ. Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Science 1992 ; 258 : 1112-8.
54. Hu WS, Temin HM. Effect of gamma radiation on retroviral recombination. J Virol 1992 ; 66 : 4457-63.
55. DeStefano JJ, Mallaber LM, Rodriguez-Rodriguez L, Fay PJ, Bambara RA. Requirements for strand transfer between internal regions of heteropolymer templates by human immunodeficiency virus reverse transcriptase. J Virol 1992 ; 66 : 6370-8.
56. DeStefano JJ, Bambara RA, Fay PJ. The mechanism of human immunodeficiency virus reverse transcriptase-catalyzed strand transfer from internal regions of heteropolymeric RNA templates. J Biol Chem 1994 ; 269 : 161-8.
57. Wu W, Blumberg BM, Fay PJ, Bambara RA. Strand transfer mediated by human immunodeficiency virus reverse transcriptase in vitro is promoted by pausing and results in misincorporation. J Biol Chem 1995 ; 270 : 325-32.
58. Levin JG, Guo J, Rouzina I, Musier-Forsyth K. Nucleic acid chaperone activity of HIV-1 nucleocapsid protein : critical role in reverse transcription and molecular mechanism. Prog Nucleic Acid Res Mol Biol 2005 ; 80 : 217-86.
59. Rodriguez-Rodriguez L, Tsuchihashi Z, Fuentes GM, Bambara RA, Fay PJ. Influence of human immunodeficiency virus nucleocapsid protein on synthesis and strand transfer by the reverse transcriptase in vitro. J Biol Chem 1995 ; 270 : 15005-11.
60. Raja A, DeStefano JJ. Kinetic analysis of the effect of HIV nucleocapsid protein (NCp) on internal strand transfer reactions. Biochemistry 1999 ; 38 : 5178-84.
61. DeStefano JJ. Human immunodeficiency virus nucleocapsid protein stimulates strand transfer from internal regions of heteropolymeric RNA templates. Arch Virol 1995 ; 140 : 1775-89.
62. Derebail SS, Heath MJ, DeStefano JJ. Evidence for the differential effects of nucleocapsid protein on strand transfer in various regions of the HIV genome. J Biol Chem 2003 ; 278 : 15702-12.
63. Kim JK, Palaniappan C, Wu W, Fay PJ, Bambara RA. Evidence for a unique mechanism of strand transfer from the transactivation response region of HIV-1. J Biol Chem 1997 ; 272 : 16769-77.
64. Negroni M, Buc H. Copy-choice recombination by reverse transcriptases : reshuffling of genetic markers mediated by RNA chaperones. Proc Natl Acad Sci USA 2000 ; 97 : 6385-90.
65. Roda RH, Balakrishnan M, Kim JK, Roques BP, Fay PJ, Bambara RA. Strand Transfer Occurs in Retroviruses by a Pause-initiated Two-step Mechanism. J Biol Chem 2002 ; 277 : 46900-11.
66. Moumen A, Polomack L, Unge T, Veron M, Buc H, Negroni M. Evidence for a mechanism of recombination during reverse transcription dependent on the structure of the acceptor RNA. J Biol Chem 2003 ; 278 : 15973-82.
67. Negroni M, Buc H. Recombination during reverse transcription : an evaluation of the role of the nucleocapsid protein. J Mol Biol 1999 ; 286 : 15-31.
68. Gao WY, Cara A, Gallo RC, Lori F. Low levels of deoxynucleotides in peripheral blood lymphocytes : a strategy to inhibit human immunodeficiency virus type 1 replication. Proc Natl Acad Sci USA 1993 ; 90 : 8925-8.
69. Pfeiffer JK, Topping RS, Shin NH, Telesnitsky A. Altering the intracellular environment increases the frequency of tandem repeat deletion during Moloney murine leukemia virus reverse transcription. J Virol 1999 ; 73 : 8441-7.
70. Svarovskaia ES, Delviks KA, Hwang CK, Pathak VK. Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching. J Virol 2000 ; 74 : 7171-8.
71. Perno CF, Yarchoan R, Cooney DA, et al. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2′, 3′-dideoxynucleosides. J Exp Med 1988 ; 168 : 1111-25.
72. O'Brien WA, Namazi A, Kalhor H, Mao SH, Zack JA, Chen IS. Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J Virol 1994 ; 68 : 1258-63.
73. Balakrishnan M, Fay PJ, Bambara RA. The Kissing Hairpin Sequence Promotes Recombination within the HIV-I 5′ Leader Region. J Biol Chem 2001 ; 276 : 36482-92.
74. Moumen A, Polomack L, Roques B, Buc H, Negroni M. The HIV-1 repeated sequence R as a robust hot-spot for copy-choice recombination. Nucleic Acids Res 2001 ; 29 : 3814-21.
75. Galetto R, Moumen A, Giacomoni V, Veron M, Charneau P, Negroni M. The structure of HIV-1 genomic RNA in the gp120 gene determines a recombination hot spot in vivo. J Biol Chem 2004 ; 279 : 36625-32.
76. Suo Z, Johnson KA. Effect of RNA secondary structure on the kinetics of DNA synthesis catalyzed by HIV-1 reverse transcriptase. Biochemistry 1997 ; 36 : 12459-67.
77. Roda RH, Balakrishnan M, Hanson MN, et al. Role of the Reverse Transcriptase, Nucleocapsid Protein, and Template Structure in the Two-step Transfer Mechanism in Retroviral Recombination. J Biol Chem 2003 ; 278 : 31536-46.
78. Klasens BI, Huthoff HT, Das AT, Jeeninga RE, Berkhout B. The effect of template RNA structure on elongation by HIV-1 reverse transcriptase. Biochim Biophys Acta 1999 ; 1444 : 355-70.
79. Hong MK, Harbron EJ, O'Connor DB, et al. Nucleic acid conformational changes essential for HIV-1 nucleocapsid protein-mediated inhibition of self-priming in minus-strand transfer. J Mol Biol 2003 ; 325 : 1-10.
80. Beltz H, Azoulay J, Bernacchi S, et al. Impact of the terminal bulges of HIV-1 cTAR DNA on its stability and the destabilizing activity of the nucleocapsid protein NCp7. J Mol Biol 2003 ; 328 : 95-108.
81. Beltz H, Piemont E, Schaub E, et al. Role of the structure of the top half of HIV-1 cTAR DNA on the nucleic acid destabilizing activity of the nucleocapsid protein NCp7. J Mol Biol 2004 ; 338 : 711-23.
82. Heilman-Miller SL, Wu T, Levin JG. Alteration of nucleic acid structure and stability modulates the efficiency of minus-strand transfer mediated by the HIV-1 nucleocapsid protein. J Biol Chem 2004 ; 279 : 44154-65.
83. Kanevsky I, Chaminade F, Ficheux D, et al. Specific interactions between HIV-1 nucleocapsid protein and the TAR element. J Mol Biol 2005 ; 348 : 1059-77.
84. An W, Telesnitsky A. Effects of varying sequence similarity on the frequency of repeat deletion during reverse transcription of a human immunodeficiency virus type 1 vector. J Virol 2002 ; 76 : 7897-902.
85. Pfeiffer JK, Telesnitsky A. Effects of limiting homology at the site of intermolecular recombinogenic template switching during Moloney murine leukemia virus replication. J Virol 2001 ; 75 : 11263-74.
86. Zhang J, Temin HM. Rate and mechanism of nonhomologous recombination during a single cycle of retroviral replication. Science 1993 ; 259 : 234-8.
87. Zhang J, Temin HM. Retrovirus recombination depends on the length of sequence identity and is not error prone. J Virol 1994 ; 68 : 2409-14.
88. Zhuang J, Jetzt AE, Sun G, et al. Human immunodeficiency virus type 1 recombination : rate, fidelity, and putative hot spots. J Virol 2002 ; 76 : 11273-82.
89. Baird HA, Galetto R, Gao Y, et al. Sequence determinants of breakpoint location during HIV-1 intersubtype recombination. Nucleic Acids Res (In Press).
90. Liu SL, Mittler JE, Nickle DC, et al. Selection for human immunodeficiency virus type 1 recombinants in a patient with rapid progression to AIDS. J Virol 2002 ; 76 : 10674-84.
91. Shriner D, Rodrigo AG, Nickle DC, Mullins JI. Pervasive genomic recombination of HIV-1 in vivo. Genetics 2004 ; 167 : 1573-83.
92. Najera R, Delgado E, Perez-Alvarez L, Thomson MM. Genetic recombination and its role in the development of the HIV-1 pandemic. AIDS 2002 ; 16 (Suppl 4) ; S3-16.
93. Shankarappa R, Margolick JB, Gange SJ, et al. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 1999 ; 73 : 10489-502.
94. Molla A, Korneyeva M, Gao Q, et al. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nat Med 1996 ; 2 : 760-6.
95. Finzi D, Blankson J, Siliciano JD, et al. Latent infection of CD4 + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 1999 ; 5 : 512-7.
96. Martinez-Picado J, DePasquale MP, Kartsonis N, et al. Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc Natl Acad Sci USA 2000 ; 97 : 10948-53.
97. Larder BA, Kellam P, Kemp SD. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro. Nature 1993 ; 365 : 451-3.
98. Gaschen B, Taylor J, Yusim K, et al. Diversity considerations in HIV-1 vaccine selection. Science 2002 ; 296 : 2354-60.
99. Moore JP, Parren PW, Burton DR. Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development. J Virol 2001 ; 75 : 5721-9.
100. Seaman MS, Xu L, Beaudry K, et al. Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys. J Virol 2005 ; 79 : 2956-63.
101. van der Groen G, Nyambi PN, Beirnaert E, et al. Genetic variation of HIV type 1 : relevance of interclade variation to vaccine development. AIDS Res Hum Retroviruses 1998 ; 14 (Suppl 3) : S211-S221.
102. Letvin NL, Huang Y, Chakrabarti BK, et al. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys. J Virol 2004 ; 78 : 7490-7.
103. Chen B, Vogan EM, Gong H, Skehel JJ, Wiley DC, Harrison SC. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 2005 ; 433 : 834-41.
104. Burton DR, Barbas CF, Persson MA, Koenig S, Chanock RM, Lerner RA. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci USA 1991 ; 88 : 10134-7.
105. Barbas CF, Bjorling E, Chiodi F, et al. Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc Natl Acad Sci USA 1992 ; 89 : 9339-43.
106. Burton DR, Pyati J, Koduri R, et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 1994 ; 266 : 1024-7.
107. Roben P, Moore JP, Thali M, Sodroski J, Barbas CF, Burton DR. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J Virol 1994 ; 68 : 4821-8.
108. Cho MW, Lee MK, Chen CH, Matthews T, Martin MA. Identification of gp120 regions targeted by a highly potent neutralizing antiserum elicited in a chimpanzee inoculated with a primary human immunodeficiency virus type 1 isolate. J Virol 2000 ; 74 : 9749-54.
109. Pantaleo G, Koup RA. Correlates of immune protection in HIV-1 infection : what we know, what we don't know, what we should know. Nat Med 2004 ; 10 : 806-10.
110. Robertson DL, Hahn BH, Sharp PM. Recombination in AIDS viruses. J Mol Evol 1995 ; 40 : 249-59.